Drug Combination Therapy will now be integrated into Pharmacology Discovery (ISSN: 3021-1913). This strategic consolidation aims to enhance our platform's capability in exploring the synergistic effects of combined drug therapies, fostering advancements in pharmacological research. It covers the many disciplines involved such as pharmacology, pharmacy, toxicology, pharmacokinetics, molecular biology, cell biology, and clinical medicine. For the latest published articles, please visit Pharmacology Discovery .